Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
40.68%
↓ 76% below average
Average (4y)
167.76%
Historical baseline
Range
High:633.58%
Low:0.00%
Volatility
377.7%
High variability
| Period | Value |
|---|---|
| 2024 | 40.68% |
| 2023 | 89.94% |
| 2022 | 74.58% |
| 2021 | 633.58% |
| 2020 | 0.00% |